Handheld device for doing blood tests moves closer to medical use

Feb 01, 2012
Handheld device for doing blood tests moves closer to medical use

Scientists are reporting a key advance in efforts to develop a handheld device that could revolutionize the complete blood cell count (CBC), one of the most frequently performed blood tests used to diagnose and treat disease. In a report in ACS' journal Analytical Chemistry, they describe adding a key feature to their "blood lab-on-a-chip" that allows it to count white blood cells more accurately.

Hywel Morgan, Cees van Berkel and colleagues explain that current CBC technology requires expensive equipment housed in central laboratories, which can take several days to process tests. The CBC test measures levels of the different components of human blood, including red and . High or low levels of certain components can indicate a variety of conditions, ranging from infections and anemia to certain forms of cancer. Hoping to make those diagnoses faster and easier, Morgan and van Berkel have been working on a handheld device similar to the blood sugar tests used by people with diabetes.

In their latest advance, the scientists describe successfully adding a new feature to the chip, which sends a blood sample through channels only a few times as wide as a human hair to an electrode that counts blood cells as they pass. The feature breaks down in a way that allows the chip to count white blood cells more accurately. Tests on from patients produced results comparable to those from tests performed on the same samples by a full-scale hematology lab.

Explore further: Novel 'butterfly' molecule could build new sensors, photoenergy conversion devices

More information: Microfluidic Lysis of Human Blood for Leukocyte Analysis Using Single Cell Impedance Cytometry, Anal. Chem., 2012, 84 (2), pp 1070–1075. DOI: 10.1021/ac202700x

Abstract
This paper demonstrates an integrated microfluidic system that performs a full blood count using impedance analysis. A microfluidic network design for red blood cell (RBC) lysis is presented, and the diffusive mixing processes are analyzed using experimental and simulated results. Healthy and clinical bloods analyzed with this system, and the data shows good correlation against data obtained from commercial hematology machines. The data from the microfluidic system was compared against hospital data for 18 clinical samples, giving R2 (coefficient of determination) values of 0.99 for lymphocytes, 0.89 for monocytes, and 0.99 for granulocytes in terms of relative counts and 0.94 for lymphocytes, 0.91 for monocytes, and 0.95 for granulocytes in terms of absolute counts. This demonstrates the potential clinical utility of this new system for a point-of-care purpose.

add to favorites email to friend print save as pdf

Related Stories

First paper 'dipstick' test for determining blood type

Jun 02, 2010

Scientists are reporting development of the first "dipstick" test for instantly determining a person's blood type at a cost of just a few pennies. Their study on the test, which involves placing a drop of ...

Reliable Home Fertility Test in Sight

Feb 16, 2010

(PhysOrg.com) -- A new 'fertility chip', developed by researchers at the University of Twente’s MESA+ Institute for Nanotechnology (The Netherlands), can accurately count spermatozoa in sperm. This is an ...

Recommended for you

Team pioneers strategy for creating new materials

Aug 29, 2014

Making something new is never easy. Scientists constantly theorize about new materials, but when the material is manufactured it doesn't always work as expected. To create a new strategy for designing materials, ...

Plug n' Play protein crystals

Aug 29, 2014

Almost a hundred years ago in 1929 Linus Pauling presented the famous Pauling's Rules to describe the principles governing the structure of complex ionic crystals. These rules essentially describe how the ...

Protein glue shows potential for use with biomaterials

Aug 28, 2014

Researchers at the University of Milan in Italy have shown that a synthetic protein called AGMA1 has the potential to promote the adhesion of brain cells in a laboratory setting. This could prove helpful ...

User comments : 0